152 related articles for article (PubMed ID: 37170725)
1. Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer.
Chang CS; Ryu JY; Choi JK; Cho YJ; Choi JJ; Hwang JR; Choi JY; Noh JJ; Lee CM; Won JE; Han HD; Lee JW
J Gynecol Oncol; 2023 Sep; 34(5):e58. PubMed ID: 37170725
[TBL] [Abstract][Full Text] [Related]
2. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
[TBL] [Abstract][Full Text] [Related]
3. Linalool-Incorporated Nanoparticles as a Novel Anticancer Agent for Epithelial Ovarian Carcinoma.
Han HD; Cho YJ; Cho SK; Byeon Y; Jeon HN; Kim HS; Kim BG; Bae DS; Lopez-Berestein G; Sood AK; Shin BC; Park YM; Lee JW
Mol Cancer Ther; 2016 Apr; 15(4):618-27. PubMed ID: 26861249
[TBL] [Abstract][Full Text] [Related]
4. Preclinical assessment of the VEGFR inhibitor axitinib as a therapeutic agent for epithelial ovarian cancer.
Paik ES; Kim TH; Cho YJ; Ryu J; Choi JJ; Lee YY; Kim TJ; Choi CH; Kim WY; Sa JK; Lee JK; Kim BG; Bae DS; Han HD; Ahn HJ; Lee JW
Sci Rep; 2020 Mar; 10(1):4904. PubMed ID: 32184452
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma.
Lee YY; Jeon HK; Hong JE; Cho YJ; Ryu JY; Choi JJ; Lee SH; Yoon G; Kim WY; Do IG; Kim MK; Kim TJ; Choi CH; Lee JW; Bae DS; Kim BG
Oncotarget; 2015 Oct; 6(33):35040-50. PubMed ID: 26418900
[TBL] [Abstract][Full Text] [Related]
6. Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer.
Shim JI; Ryu JY; Jeong SY; Cho YJ; Choi JJ; Hwang JR; Choi JY; Sa JK; Lee JW
Gynecol Oncol; 2022 May; 165(2):270-280. PubMed ID: 35305818
[TBL] [Abstract][Full Text] [Related]
7. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice.
Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.
Lee JW; Ryu JY; Yoon G; Jeon HK; Cho YJ; Choi JJ; Song SY; Do IG; Lee YY; Kim TJ; Choi CH; Kim BG; Bae DS
Int J Cancer; 2015 Jul; 137(1):221-9. PubMed ID: 25429856
[TBL] [Abstract][Full Text] [Related]
9. The role of a drug-loaded poly (lactic co-glycolic acid) (PLGA) copolymer stent in the treatment of ovarian cancer.
Wang Y; Qiao X; Yang X; Yuan M; Xian S; Zhang L; Yang D; Liu S; Dai F; Tan Z; Cheng Y
Cancer Biol Med; 2020 Feb; 17(1):237-250. PubMed ID: 32296591
[No Abstract] [Full Text] [Related]
10. CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer.
Kim J; Cho YJ; Ryu JY; Hwang I; Han HD; Ahn HJ; Kim WY; Cho H; Chung JY; Hewitt SM; Kim JH; Kim BG; Bae DS; Choi CH; Lee JW
Gynecol Oncol; 2020 Jan; 156(1):211-221. PubMed ID: 31776040
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
Li S; Li X; Ding J; Han L; Guo X
Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
[No Abstract] [Full Text] [Related]
12. Folate receptor-targeted PLGA-PEG nanoparticles for enhancing the activity of genistein in ovarian cancer.
Patra A; Satpathy S; Naik PK; Kazi M; Hussain MD
Artif Cells Nanomed Biotechnol; 2022 Dec; 50(1):228-239. PubMed ID: 36330543
[TBL] [Abstract][Full Text] [Related]
13. Non-small cell lung cancer tumour antigen, MUC-1 peptide-loaded non-aggregated poly (lactide-
Jyoti K; Jain S; Katare OP; Katyal A; Chandra R; Madan J
J Microencapsul; 2020 Jan; 37(1):14-28. PubMed ID: 31718364
[No Abstract] [Full Text] [Related]
14. Pigment epithelial-derived factor gene loaded novel COOH-PEG-PLGA-COOH nanoparticles promoted tumor suppression by systemic administration.
Yu T; Xu B; He L; Xia S; Chen Y; Zeng J; Liu Y; Li S; Tan X; Ren K; Yao S; Song X
Int J Nanomedicine; 2016; 11():743-59. PubMed ID: 26955272
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-Mediated Long-Circulating Nanopolymer Delivery of Therapeutic siRNA and Antisense MicroRNAs Leads to Enhanced Paclitaxel Sensitivity in Epithelial Ovarian Cancer Chemotherapy.
Liu Y; Long T; Zhang N; Qiao B; Yang Q; Luo Y; Cao J; Luo J; Yuan D; Sun Y; Li Y; Yang Z; Wang ZG
ACS Biomater Sci Eng; 2020 Jul; 6(7):4036-4050. PubMed ID: 33463352
[TBL] [Abstract][Full Text] [Related]
16. Reduced Cardiotoxicity of Ponatinib-Loaded PLGA-PEG-PLGA Nanoparticles in Zebrafish Xenograft Model.
Al-Thani HF; Shurbaji S; Zakaria ZZ; Hasan MH; Goracinova K; Korashy HM; Yalcin HC
Materials (Basel); 2022 Jun; 15(11):. PubMed ID: 35683259
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages.
Guedj AS; Kell AJ; Barnes M; Stals S; Gonçalves D; Girard D; Lavigne C
Int J Nanomedicine; 2015; 10():5965-79. PubMed ID: 26445538
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice.
Sasaki K; Nishina S; Yamauchi A; Fukuda K; Hara Y; Yamamura M; Egashira K; Hino K
Cell Mol Gastroenterol Hepatol; 2021; 11(3):739-762. PubMed ID: 33191170
[TBL] [Abstract][Full Text] [Related]
19. LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.
Hiramatsu K; Serada S; Enomoto T; Takahashi Y; Nakagawa S; Nojima S; Morimoto A; Matsuzaki S; Yokoyama T; Takahashi T; Fujimoto M; Takemori H; Ueda Y; Yoshino K; Morii E; Kimura T; Naka T
Cancer Res; 2018 Jan; 78(2):516-527. PubMed ID: 29187404
[TBL] [Abstract][Full Text] [Related]
20. Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.
Devulapally R; Sekar TV; Paulmurugan R
Mol Pharm; 2015 Jun; 12(6):2080-92. PubMed ID: 25880495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
